4//SEC Filing
Singh Enakshi 4
Accession 0001645842-22-000120
CIK 0001645842other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:50 PM ET
Size
5.2 KB
Accession
0001645842-22-000120
Insider Transaction Report
Form 4
Singh Enakshi
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-08-30$2.27/sh−15,365$34,946→ 469,955 total
Footnotes (2)
- [F1]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $2.31 and no less than $2.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Zymergen Inc.
CIK 0001645842
Entity typeother
Related Parties
1- filerCIK 0001846617
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:50 PM ET
- Size
- 5.2 KB